Investor presentation
Filed with ASX · · 25 pages · English
In the deck
Earlier from Argent Biopharma
- Mxc completes first ArtemiC order, March qtr record revenue
- Ethics Committee Approval Granted Phase III Clinical Trial
- SwissPharmaCan AG increases initial purchase order
- MGC Pharma first medicinal cannabis company to list on LSE
- MGC Pharma Investor Presentation
Later from Argent Biopharma
- MGC pharma to acquire medical research company MediCaNL
- March quarterly activity and cashflow report
- ArtemiC submitted to Health Canada
- $1M order for ArtemiC Rescue from swiss PharmaCan
- Further findings on ArtemiC as anti-inflammatory agent
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma